PepsiCo earnings beat estimates even as U.S. demand falls

PepsiCo earnings beat estimates even as U.S. demand falls


Cases of Pepsi soda are displayed at a Costco Wholesale store on April 25, 2025 in San Diego, California.

Kevin Carter | Getty Images

PepsiCo on Thursday reported quarterly earnings and revenue that topped analysts’ expectations, despite weaker demand for its food and drinks in North America.

Shares of the company rose roughly 2% in premarket trading.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: $2.12 adjusted vs. $2.03 expected
  • Revenue: $22.73 billion vs. $22.27 billion expected

Pepsi reported second-quarter net income attributable to the company of $1.26 billion, or 92 cents per share, down from $3.08 billion, or $2.23 per share, a year earlier.

Excluding restructuring and impairment charges and other items, the company earned $2.12 per share.

Net sales rose 1% to $22.73 billion. The company’s organic revenue, which excludes acquisitions, divestitures and foreign currency, increased 2.1% during the quarter.

But the company is still seeing softer demand for its products. Pepsi’s worldwide volume fell 1.5% for its food and was flat for its drinks. The metric strips out pricing and foreign exchange changes.

Volume fell again in North America, although CEO Ramon Laguarta said in a statement that the domestic business is improving. The company’s North American food division, which includes both Frito-Lay and Quaker Foods, saw its volume shrink 1%. Pepsi’s domestic drinks segment reported that its volume fell 2% in the quarter.

As part of Pepsi’s strategy to boost its North American sales, it’s leaning into the protein craze and multicultural product offerings, like those from Siete Foods and Sabra. The company is also working on ensuring better in-store availability and placement of its products.

Pepsi reiterated its full-year outlook. It still expects its core constant currency earnings per share to be roughly unchanged from the prior year and organic revenue to grow by a low-single digit percentage.

Last quarter, the company cut its earnings forecast, citing new tariffs, economic volatility and a more cautious consumer.



Source

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Business

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency.  Schwartz will have to be confirmed by the Senate, […]

Read More
RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Business

RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Piotr Swat | Lightrocket | Getty Images As its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding a new opportunity in peptides. Shares of the telehealth company jumped Thursday after HHS Secretary Robert F. Kennedy Jr. announced Wednesday that the FDA plans to convene a Pharmacy Compounding Advisory Committee meeting to […]

Read More
Netflix reports earnings after the bell. Here’s what to expect
Business

Netflix reports earnings after the bell. Here’s what to expect

The Netflix logo is seen on an office building in Los Angeles, California, on Feb. 5, 2026. Michael Yanow | Nurphoto | Getty Images Netflix kicks off earnings season for media companies on Thursday with a quarterly report that Wall Street hopes will give more updates on the company’s path forward after walking away from […]

Read More